To The Moon

SPY Likely to Extend Correction in Double Three Structure August 22, 2023 By EWFHendra Short Term Elliott Wave view in S&P 500 ETF (SPY) suggests the decline from 7.27.2023 high is in progress as a double three Elliott Wave structure. Down from 7.27.2023 high, wave ((a)) ended at 444.96 and rally in wave ((b)) ended at 451.7. The ETF then extended lower in wave ((c)). Down from wave ((b)), wave (i) ended at 443.35 and rally in wave (ii) ended at 448.92. The ETF extended lower again in wave (iii) towards 433.93 and wave (iv) rally ended at 436.77. Final leg wave (v) lower ended at 433.05 which completed wave ((c)) of W. Wave X rally is now in progress to correct cycle from 7.27.2023 high before the next leg lower. Up from wave W, wave i ended at 436.55 and wave ii ended at 434.38. Wave

All eyes are on $NVIDIA Corp(NVDA)$ , a chipmaking giant that has become synonymous with the explosive growth of artificial intelligence. Investors and analysts alike are anxiously awaiting the company's earnings report, which has the potential to send ripples through the market. The European stocks and US equity futures registered a climb, with optimism building around Nvidia's impending results. This chipmaker has been at the forefront of the AI revolution, propelling itself into the limelight and driving considerable excitement in the tech sector. The stock action is closely watched, given Nvidia's significant weight in the market. Accounting for over 3% of the S&P 500, its performance could have far-reaching

The renowned sporting goods retailer has long been a destination for athletes and outdoor enthusiasts. However, recent financial turbulence has left investors and analysts questioning the company's outlook, as $Dick's Sporting Goods(DKS)$ grapples with unexpected challenges in the wake of its earnings report. Dick's In a surprising turn of events, Dick's reported a sharp drop in quarterly profit, sending shockwaves through the financial world. Despite a seemingly positive 3.6% increase in sales, the company's net income for the second quarter plummeted by a staggering 23% compared to the previous year. This bewildering disparity between sales growth and profit decline has raised eyebrows and cast a spotlight on the underlying issues plaguing the co

Moderna stock remains under pressure despite winning authorization for its omicron-blocking booster shots in multiple global regions, including the U.S.X0 seconds of 15 secondsVolume 0%Regulators in Japan, Canada, Europe, the U.S., Australia, Switzerland and the U.K. have all signed off onModerna's (MRNA) omicron-blocking booster. The company has two iterations, one capable of handling the BA.1 sub-variant and another that blocks the BA.4/BA.5 strains.Bullishly, Moderna reported unexpected sales growth in the second quarter. Sales of the Covid vaccine called Spikevax grew 8% to $4.53 billion. Analysts expected a sales decline of 9% to $3.83 billion. The results sent Moderna stock soaring for two days, then shares quickly hit the skids.Moderna also won FDA authorization for its Covid vaccin

U.S. stocks rose sharply on Tuesday as major stock indexes rebounded after recording their worst week of performance in two years last week. $S&P 500(.SPX)$ $NASDAQ(.IXIC)$Led by a rebound in European stocks and Asian equities, the bear market reversal in U.S. stocks is not driven by a single condition.The prevailing view is that any recent rebound will be nothing more than a "dead cat bounce" that will eventually end in failure. A dead cat jump is usually a rally that lacks fundamental support and is likely to be followed by renewed weakness.Market opinions diverge:Oppenheimer: 7 of 10 indicators on the market bottom checklist is yes!According&